Recombinant Antibody Technologies    

Services include:

• Selection of recombinant antibody fragments (scFv, Fab) using phage display technologies
  – Screening of antibody libraries for recognition of protein, peptide, and nucleic acid targets
  – Identification and characterization of antibody binding epitopes
  – Functional validation of antibody–target interactions
  – Development of antibody-based molecular detection tools

Molecular Microbiology and Immunology

Scylla Biotech offers experimental support for research projects focused on host–pathogen interactions and immune recognition mechanisms.

Services include:

• Analysis of innate immune responses to microbial and viral components
  – Functional studies of immune receptors and signaling pathways
  – Characterization of bacterial virulence factors and extracellular vesicles
  – Cell-based assays to assess immune activation and inflammatory responses

RNA-based Technologies and Molecular Recognition

Scylla Biotech develops molecular tools for the detection and analysis of therapeutic oligonucleotides and RNA-based technologies.

Services include:

• Development of molecular recognition tools for modified oligonucleotides
  – Design of experimental models to investigate interactions between RNA therapeutics and biological systems
  – Evaluation of cellular responses to nucleic acid-based molecules
  – Development of analytical assays for RNA-focused research applications